ADENURIC 120 mg, film-coated tablet 28 tablets, CIP 3400938572506
Active ingredients: FÉBUXOSTAT
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet28 tablets, CIP 3400938572506orale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ADENURIC 120 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 2 plaquette(s) thermoformée(s) (ACLAR RX) polytrifluorochloroéthylène PVC-Aluminium de 14 comprimé(s)
- Marketing authorisation holder
- MENARINI INTERNATIONAL OPERATIONS LUXEMBOURG
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 12 Feb 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
64493890CIP73857250CIP133400938572506Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FÉBUXOSTATcomprimé | 120 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: FEBUXOSTAT 120 mg - ADENURIC 120 mg, comprimé pelliculé